Rein Therapeutics, Inc. cotiza a 0.75 USD y tiene una capitalización bursátil de $65M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide, which is in Phase 2 clinical trial for the treatment of idiopathic pulmonary f…
| Métrica | RNTX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -294.8% | -40.4% | -254.4% |
| ROA | -206.4% | -32.0% | -174.4% |
| Current Ratio | 0.70 | 2.84 | -2.14 |
| Debt / Equity | — | 0.28 | — |